IL HB1721

Requires prescription drug manufacturers selling or distributing drugs in Illinois to notify the Department of Public Health about the country of origin for active pharmaceutical ingredients, searchable by brand name and generic chemical name

Mandates disclosure of country of origin for each dosage form or route of administration if sourcing varies by these factors

Requires manufacturers to provide Drug Master File numbers for angiotensin II receptor blockers (blood pressure medications) and certify that nitrosamine contamination levels show "Not Detected"

Requires disclosure of Drug Master File numbers for any active pharmaceutical ingredient with nitrosamine specification controls due to manufacturing processes using recycled solvents or catalysts

Amends the Illinois Food, Drug and Cosmetic Act by adding Section 3.24 addressing active pharmaceutical ingredient transparency